On Lumping, Splitting, and the Nosology of Clinical Trial Populations and End Points Reply

被引:0
|
作者
Ballman, Karla V. [1 ]
Mauer, Murielle [2 ,3 ]
Wedding, Ulrich [2 ,4 ,5 ]
Mohile, Supriya G. [6 ]
Muss, Hyman [7 ,8 ]
Extermann, Martine [3 ,9 ]
Luciani, Andrea [2 ,10 ]
Cohen, Harvey Jay [4 ,7 ,11 ,12 ]
Hurria, Arti [4 ,7 ,13 ,14 ]
Lichtman, Stuart M. [4 ,15 ,16 ]
Curigliano, Giuseppe [2 ,17 ]
Wildiers, Hans [2 ,4 ,18 ]
机构
[1] Mayo Clin, Rochester, MN 55905 USA
[2] European Org Res Treatment Canc, Elderly Task Force, Brussels, Belgium
[3] European Org Res Treatment Canc, Brussels, Belgium
[4] Int Soc Geriatr Oncol, Geneva, Switzerland
[5] Jena Univ Hosp, Jena, Germany
[6] Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY USA
[7] Alliance, Chicago, IL USA
[8] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[9] Univ S Florida, Moffitt Canc Ctr, Tampa, FL USA
[10] S Paolo Hosp, Milan, Italy
[11] Duke Univ, Ctr Study Aging & Human Dev, Durham, NC USA
[12] Duke Univ, Ctr Comprehens Canc, Durham, NC USA
[13] City Hope Comprehens Canc Ctr, Duarte, CA USA
[14] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA
[15] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[16] Weill Cornell Med Coll, New York, NY USA
[17] European Inst Oncol, Milan, Italy
[18] Univ Hosp Leuven, Louvain, Belgium
关键词
INTERNATIONAL-SOCIETY; CANCER;
D O I
10.1200/JCO.2013.54.5236
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1090 / 1091
页数:2
相关论文
共 50 条
  • [21] Severe Asthma: Pragmatic Clinical Lumping and Time for Investigational Splitting
    Israel, Elliot
    Papi, Alberto
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189 (06) : 619 - 620
  • [22] Clinical subtypes and genetic heterogeneity: of lumping and splitting in Parkinson disease
    von Coelln, Rainer
    Shulman, Lisa M.
    CURRENT OPINION IN NEUROLOGY, 2016, 29 (06) : 727 - 734
  • [23] DESIGN OF CLINICAL-TRIAL - END-POINTS - CONSIDERATIONS IN THE SELECTION OF END-POINTS FOR AIDS CLINICAL-TRIALS
    AMATO, DA
    LAGAKOS, SW
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1990, 3 : S64 - S68
  • [24] REPLY: SPLITTING OVER LUMPING IN MECHANICAL SUPPORT FOR ACUTE RESPIRATORY DISTRESS SYNDROME
    Grant, Michael C.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2021, 161 (02): : E214 - E215
  • [25] Clinical Trial End Points in Severe COVID-19
    Desai, Aakash
    Kulkarni, Amit
    Rajkumar, S. Vincent
    Gyawali, Bishal
    MAYO CLINIC PROCEEDINGS, 2020, 95 (08) : 1578 - 1580
  • [26] End Points and Clinical Trial Design in Pulmonary Arterial Hypertension
    McLaughlin, Vallerie V.
    Badesch, David B.
    Delcroix, Marion
    Fleming, Thomas R.
    Gaine, Sean P.
    Galie, Nazzareno
    Gibbs, J. Simon R.
    Kim, Nick H.
    Oudiz, Ronald J.
    Peacock, Andrew
    Provencher, Steeve
    Sitbon, Olivier
    Tapson, Victor F.
    Seeger, Werner
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (01) : S97 - S107
  • [27] Surrogate end points and their role in clinical trials: Reply from authors
    Kalikar, M. V.
    Thawani, V. R.
    Varadpande, U. K.
    Sontakke, S. D.
    Singh, R. P.
    Khiyani, R. K.
    INDIAN JOURNAL OF PHARMACOLOGY, 2009, 41 (01) : 55 - 55
  • [28] Clinical trial end points in malignant glioma: Need for effective trial design strategy
    Brada, M
    Yung, WKA
    SEMINARS IN ONCOLOGY, 2000, 27 (03) : S11 - S19
  • [29] Toward Smarter Lumping and Smarter Splitting: Rethinking Strategies for Sepsis and Acute Respiratory Distress Syndrome Clinical Trial Design
    Prescott, Hallie C.
    Calfee, Carolyn S.
    Thompson, B. Taylor
    Angus, Derek C.
    Liu, Vincent X.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 194 (02) : 147 - 155
  • [30] Clinical trials and surrogate end points: lessons from the ENHANCE trial
    Farmer, John Alan
    FUTURE LIPIDOLOGY, 2008, 3 (04): : 353 - 357